Revance Therapeutics (RVNC) Free Cash Flow (2014 - 2024)
Revance Therapeutics (RVNC) free cash flow from Mar 31, 2014 to Sep 30, 2024. The TTM Revance Therapeutics (RVNC) free cash flow is -$205M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Revance Therapeutics (RVNC) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -2.67% |
| 3 Years TTM | -6.03% |
| 5 Years TTM | +13.66% |
| 10 Years TTM | +14.86% |
| All Time TTM | +14.92% |
Annual Free Cash Flow change of Revance Therapeutics (RVNC)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2024 | -$161M | -28.04% |
| 2023 | -$223M | +13.57% |
| 2022 | -$197M | -15.16% |
| 2021 | -$232M | +27.00% |
| 2020 | -$183M | +66.93% |
| 2019 | -$109M | -1.66% |
| 2018 | -$111M | +13.56% |
| 2017 | -$98M | +54.76% |
| 2016 | -$63M | +7.29% |
| 2015 | -$59M | -4.90% |
| 2014 | -$62M | N/A |